The International Pharmacopoeia

From WikiMD's WELLNESSPEDIA

The International Pharmacopoeia (Ph. Int.) is a collection of quality specifications for pharmaceutical substances and dosage forms, together with supporting general methods of analysis. Its purpose is to serve as source material for reference or adaptation by any World Health Organization (WHO) Member State wishing to establish pharmaceutical requirements.

History[edit]

The International Pharmacopoeia was first published by the World Health Organization (WHO) in 1951. It was developed in response to the need for internationally harmonized specifications for pharmaceutical substances and dosage forms. The first edition contained only 28 monographs. Over the years, the publication has grown and the sixth edition, published in 2016, contains more than 400 monographs.

Purpose[edit]

The main purpose of The International Pharmacopoeia is to promote and protect public health. It does this by providing internationally recognized and accepted quality standards and specifications for pharmaceutical substances and dosage forms, along with associated analytical methods. These standards are used by regulatory authorities, pharmaceutical industries, and laboratories worldwide to ensure that medicines are of the required quality.

Content[edit]

The International Pharmacopoeia contains monographs for pharmaceutical substances and dosage forms, along with test methods, reagents, and apparatus that are necessary for implementing the monographs. The substances included are selected on the basis of worldwide use and importance. The monographs are developed through a consultative process involving WHO Member States, WHO Expert Committees, and partner organizations.

Use[edit]

The International Pharmacopoeia is used by national and regional regulatory authorities, pharmaceutical manufacturers, and quality control laboratories. It serves as a basis for national and regional pharmacopoeias and is used to establish national and regional standards for pharmaceutical substances and dosage forms.

See also[edit]

References[edit]


External links[edit]

  • The International Pharmacopoeia on the WHO website
This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=The_International_Pharmacopoeia&oldid=6619191"